I agree that this site is using cookies. You can find further informations here.
X
A. A. Mosikian
17  results:
Search for persons X
?
1

Pharmacoeconomic Analisys of Ixabepilone Monotherapy in Pat..:

Kolbin, A ; Mosikian, A ; Kurylev, A..
Value in Health.  20 (2017)  9 - p. A440 , 2017
Link: https://doi.org/10.1016/..
 
?
2

Prediction Scale of Response to Liraglutide Therapy As the ..:

Mosikian, Anna A ; Golikova, Tatiana I ; Martjanova, Mariia V.
Future Science OA.  8 (2022)  3 - p. , 2022
Link: https://doi.org/10.2144/..
 
?
3

Patient education: interpretation of medical terms as a key..:

Novoselova, Nataliya S. ; Mosikian, Anna A. ; Martyanova, Olga Y...
Diabetes mellitus.  21 (2019)  6 - p. 472-479 , 2019
Link: https://doi.org/10.14341..
 
?
4

Effectiveness prediction of Evogliptin treatment in type 2 ..:

Mosikian, Anna A. ; Babenko, Alina Y. ; Sevastyanova, Yulia A...
Diabetes mellitus.  21 (2018)  5 - p. 333-343 , 2018
Link: https://doi.org/10.14341..
 
?
5

Efficacy and safety of evogliptin versus sitagliptin as add..:

Babenko, Alina Y. ; Mosikian, Anna A. ; Makarenko, Igor E...
Diabetes mellitus.  21 (2018)  4 - p. 241-254 , 2018
Link: https://doi.org/10.14341..
 
?
6

Evaluation of factors influencing adherence to treatment wi..:

D. A. Lebedev ; A. A. Mosikian ; A. Yu. Babenko
https://bulletin.ssmu.ru/jour/article/view/2978.  , 2020
Link: https://doi.org/10.20538..
 
?
7

Evaluation of factors influencing adherence to treatment wi..:

D. Lebedev A ; A. Mosikian A ; A. Babenko Yu...
https://bulletin.tomsk.ru/jour/article/view/2978/1789.  , 2020
Link: https://bulletin.tomsk.r..
 
?
8

Evaluation of immunogenicity, efficacy and safety of GP4004..:

A. G. Zalevskaya ; A. A. Mosikian ; O. V. Afonkina.
https://www.clinvest.ru/jour/article/view/420.  , 2019
Link: https://doi.org/10.24411..
 
?
9

Development and Validation of Approach for the Detection of..:

N. B. Abramenko ; P. I. Vnukova ; E. S. Golovina...
https://www.pharmjournal.ru/jour/article/view/717.  , 2019
Link: https://doi.org/10.33380..
 
?
10

Decision modelling for the evaluation of diabetes outcomes:

A. A. Mosikian ; W. Zhao ; T. L. Galankin.
https://www.pharmacoeconomics.ru/jour/article/view/208.  , 2017
Link: https://doi.org/10.17749..
 
?
11

Decision modelling for the evaluation of diabetes outcomes ..:

A. Mosikian A ; W. Zhao ; T. Galankin L...
https://www.pharmacoeconomics.ru/jour/article/view/208/202.  , 2017
Link: https://www.pharmacoecon..
 
?
12

Clinical Trials in Pediatrics and Neonatology: Reasons for ..:

A. A. Mosikian ; A. O. Tomasheva ; T. L. Galankin...
https://www.pedpharma.ru/jour/article/view/1421/794.  , 2016
Link: https://www.pedpharma.ru..
 
?
13

Clinical Trials in Pediatrics and Neonatology: Reasons for ..:

A. A. Mosikian ; A. O. Tomasheva ; T. L. Galankin.
https://www.pedpharma.ru/jour/article/view/1421.  , 2016
Link: https://doi.org/10.15690..
 
?
14

Prediction scale of response to liraglutide therapy as the ..:

Anna A Mosikian ; Tatiana I Golikova ; Mariia V Martjanova.
https://www.future-science.com/doi/10.2144/fsoa-2021-0070.  , 2022
Link: https://doi.org/10.2144/..
 
?
15

Patient education: interpretation of medical terms as a key..:

Nataliya S. Novoselova ; Anna A. Mosikian ; Olga Y. Martyanova..
https://www.dia-endojournals.ru/jour/article/view/9526.  , 2018
Link: https://doi.org/10.14341..
 
1-15